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Introduction (1200-1500 words)      
Every week thousands of operations are performed worldwide. At the end of most procedures the 
skin incision is closed with sutures, clips, or adhesive strips. After skin closure it is common for a 
dressing to be applied over the wound, although in some areas of surgery the closed wounds are 
routinely left uncovered. Whether it is effective and cost effective to use dressings routinely, 
however, is uncertain.  
 
Dressings placed over an already closed wound have several theoretical benefits, although evidence 
to support these claims is weak. Practical advantages are management of wound exudates and 
prevention of wound damage from inadvertent disturbance. Psychologically, patient anxiety may be 
reduced if the incision is covered and not able to be seen. Conversely, leaving a wound without a 
dressing avoids the need for painful dressing removal and enables the patient and health care 
professionals to see the wound. Easy visibility may reduce patient anxiety about the unknown 
beneath a dressing and allow for earlier diagnosis of an impending wound problem.  In addition to 
the practical and psychological controversies that surround the use of wound dressings there is 
uncertainty about their role in the prevention of surgical site infection (SSI). Wound dressings may 
limit SSI by reducing external contamination with bacteria, or increase SSI by incubating contained 
bacteria in the local environment created by the dressing.  
Another concern related to the generally widespread use of dressings is their cost and the resource 
implications for NHS staff required to change and remove dressings. Costs vary from about £0.10 for 
a basic gauze dressing, up to £0.50 for an adhesive transparent dressing, through to expensive 
“interactive” dressings with claimed therapeutic properties that may cost up to £20 or topical 
negative pressure therapy dressings (for use on an already closed primary wound) that can cost as 
much as £100 per week (ref BNF). Tissue adhesive “glue” may also be used “as-a-dressing” on an 
already closed primary wound (refs). A vial of tissue adhesive that will cover a 20cm closed wound 
costs between £6 and £20. There are therefore a variety of practical, psychological, clinical and cost-
related issues to be considered when using a dressing or not on a primary wound.  It is, however, SSI 
risk that is most often the focus of research in this field.  
SSI is a major concern following surgery. After high risk procedures (e.g. unplanned abdominal 
surgery) SSI rates may reach 20% although in elective clean surgery SSI rates are frequently less than 
5% (<3% in hernia surgery and <1% in surgery involved prosthetic implants) (refs). Whilst many SSIs 
resolve with simple antibiotic treatment, the more serious ones cause pain, discomfort and 
inconvenience, and, after some operations, SSI will threaten the principal outcome of the procedure, 
the future health of the patient and may even be life threatening. Surgical site infection also has 
major costs for health services. Indeed it has been estimated that the NHS and societal cost of 
treating an SSI ranges from £5 to over £10K (Tanner/Jenks).  Whilst it is often a main outcome of 
research in this area, SSI can be difficult to define and measure. The existing tools used in 
surveillance and research (the Centres for Disease Control and Prevention (CDC) criteria and 
ASEPSIS) have limited validation and patient input, and do not identify SSI consistently. In addition, 
as most SSIs occur after hospital discharge capturing  real rates is challenging: surgical review of all 
wounds post-discharge is costly; measures such as receipt of antibiotics will not necessarily reflect 
the presence of a wound infection; and self-report may be inaccurate because tools have limited 
development and validation for patient use. There are also challenges in measuring other endpoints 
associated with wounds and dressings such as practical management of exudate, or patient and 
clinician experience of dressings; to date, there are no validated tools available for this purpose. 
These difficulties underline the need for methodological research in this field as well as the need to 
understand the clinical and cost-effectiveness of different dressing types or leaving closed primary 
wounds exposed without a dressing (referred to in the remainder of the paper as “no dressing”).  
 
What is the evidence of uncertainty? 
A Cochrane systematic review summarising evidence for the use of dressings to prevent SSI was 
published in 2011 and updated in 2014(refs). Twenty randomised controlled trials (RCTs) were 
included which examined types of dressing and “no dressing” on a closed primary wound to reduce 
SSI. The review did not include search terms of tissue adhesive “as-a-dressing”.  All trials were at an 
unclear or high risk of bias and included studies were underpowered to detect SSI events. Just two 
studies compared wound dressing application with leaving wounds exposed, and the remainder 
compared two types of dressing. No evidence was identified to suggest that any dressing 
significantly reduced the risk of developing an SSI compared with leaving wounds exposed; neither 
did the review show any SSI benefit associated with particular dressing types.  In the studies, 
precision around the risk of SSI occurring was often very large and uncertainty great, meaning that a 
real difference between dressings or no dressing use could not be excluded.  Given the very low 
levels of certainty around the impact of dressing approaches on SSI incidence, the review concluded 
that current decision-making around dressings may need to be informed (perhaps for pragmatic 
reasons) by costs of dressings and practical issues such as wound symptom management. It also 
recommended that, if deemed a priority area for research, the design of future trials should focus on 
surgical procedures at highest risk of an SSI, as well as evaluating the dressings or approaches that 
health professionals use most widely; importantly, the review emphasised that any such study  
should be adequately powered.  
 
We have recently updated the above review with searches to include terms for tissue adhesive “as-
a-dressing” to cover an already closed primary wound. We screened over 300 abstracts, retrieved 25 
full papers and included four RCTs (Parvizi, Romero, Grauhan, Al-Belasy). Trials were small, single 
centre, only undertaken in clinical areas and all at a high or unclear risk of bias. Currently, evidence 
for the effectiveness of tissue adhesive “as-a-dressing” is very poor.  
 
Is ongoing research likely to provide relevant evidence? 
Searches in the WHO International Clinical Trials Registry have identified on-going trials comparing 
advanced ‘interactive’ dressings with standard simple dressings. We were unable to find new main 
trials with a comparison group of “no dressing” and trials evaluating tissue adhesive “as-a-dressing”. 
There is an on-going NIHR feasibility study (The Bluebelle Study HTA 12/200/04) which will establish 
whether a definitive trial of different dressing types and “no dressing” is possible and a worthwhile 
investment for the NHS5. The feasibility work includes in-depth qualitative case studies with patients, 
surgeons, nurses and midwives exploring views and current practice of dressings, methodological 
work to improve outcome measures to use in a trial, and a pilot RCT to establish whether it is 
possible to randomise patients to “no dressing” and whether adherence to treatment allocation of 
“no dressing” is possible.  
 
What dressings should we use or not use  in the light of the uncertainty? 
In light of uncertainties in this area it is difficult to provide practical guidance for wound dressing use 
in surgery, and therefore, there is a clear need for further research  (Box 1). Perhaps an important 
step for all health professionals who regularly place dressings on already closed wounds is to 
consider the practice of others in this field - where no dressings are used and wounds are left 
exposed to heal. Whether knowledge that a dressing will not be used will influence the quality of 
skin closure is unknown. It is quite possible that if no wound dressing is planned that the skin closure 
is performed more carefully to ensure that there is less exudate making immediate practical wound 
care management acceptable to staff and patients. We suggest that surgeons reflect on the reasons 
for applying wound dressings and retain an “open mind” about whether or not they are necessary.  
We also recommend collaborative research endeavours between surgeons to answer these 
questions of importance to patients, staff and the NHS (Box 1).   
 
We have read and understood the BMJ policy on declaration of interests and do not have any 
interests to declare. Box 3 shows how patients have been involved in the development of ideas for 
this article. 
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Box 1. Recommendations for future research 
• Can valid, reliable and acceptable patient centred methods for measuring SSI be 
established? 
• Is it possible to develop an accurate and easy to use tool to assess symptoms and 
experiences associated with the practical issues of wound management in the early post-
operative setting? 
• What is the effectiveness and cost-effectiveness of tissue adhesive ‘as-a-dressing’ compared 
to standard adhesive (and/or absorbent) dressings to reduce SSI and improve practical 
wound management after surgery with a closed primary wound? 
• Can surgeons and nurses work together to undertake a very large scale randomised 
controlled trial to assess the effectiveness, cost effectiveness and patient acceptability of 
dressing types and ‘no dressings’ on closed primary wounds and is such a large trial a 
worthwhile investment for the NHS? 
 
Box 2 The bottom line 
• Surgeons! Consider leaving a carefully closed wound exposed without a dressing 
• Clinical staff changing dressings. Consider leave a wound undressed to heal.  
 
Box 3 How patients were involved in the creation of this article 
We have consulted widely with patients undergoing surgery to understand their experience of 
dressings, views of not having a dressing and the practical issues associated with incisions and 
dressings (ref Bluebelle). We have talked to patients who have tissue adhesive “as-a-dressing”. 
Patient views led us to understand the advantages and disadvantages of dressing use which are 
described in the article and they informed the need to develop better research for measuring 
practical wound management problems.   
